InvestorsHub Logo
Followers 20
Posts 3280
Boards Moderated 1
Alias Born 06/05/2020

Re: MrHankey post# 218625

Saturday, 03/18/2023 3:09:00 PM

Saturday, March 18, 2023 3:09:00 PM

Post# of 233377
Not real hard to have "both" and see why people can get to a negative hypothesis

I.E.--There have been multitudes of PRs/proactive videos that were 100% nonsense and there are MANY examples of mngmt saying/stating 1 thing--then when seeing the SEC filed docs it is complete difference in what was stated (always read the SEC docs)

So the corollary (you are alluding to) is lack of--and that is true also. There has /is a huge lack of honest information (transparency). This is from prev mngmt--so far this is also "new" mngmt.

Just a sample--in MAR of 2022 CYDY placed hold on Brazil trial --until meeting w Anvisa/DSMB. Shareholders have NEVER heard another word

In 2021 there was a huge/never solved issue with RO (receptor occupancy) . It was a requirement by FDA. CYDY tried to place blame on IncellDX (that was proven to be false) and then CYDY said they might try using "clinical data sets". Regardless CYDY said they would release "into the public domain" all the issues/shortcomings of the RO testing. This was never done

CYDY stated in 2017--that the BLA would be submitted in 1st qtr of 2018--1st half of 2018 at the latest. We all know this status.

CYDY stated for years that the CRO was doing a fantastic job. CYDY NEVER stated or filed any SEC doc showing that CRO was part of CYDY mngmt/decision making. That is certainly lack of honesty.

CYDY has stated that the BLA would require 5 parts being re-submitted. That is stuck at 3. CYDY has stated the fix for clinical holds (full /partial) will require being submitted in 5 parts. Shareholders were last told that is at 3 also. Shareholders have NEVER known allthe hold issues and if those issues can be "cured". This is approaching 1 year.

There is no new CRO. There is no RCT being conducted. At what point is it get new CRO. Conduct full dosing --conduct RO --get a RCT approved--funded-enrolling

Most of this happened under prev mngmt. New mngmt allowed the prev board chair to remain. New mngmt has never addressed Brazil/BLA/RO/funding/CRO/multiple lawsuits/I P pawn--actually this list is in the dozens

So yes--way too many lies (old AND new)
way too little honesty--accomplishments (old AND new)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News